Merit Medical Systems (FRA:MM3) Beneish M-Score: -2.73 (As of Jul. 06, 2026)


FRA:MM3 Merit Medical Systems Inc FRA:MM3
86 GF Score
Price €61.50
GF Value €83.98
Valuation Modestly Undervalued
View Full Analysis

What is Merit Medical Systems Beneish M-Score?

Merit Medical Systems FRA:MM3 +2.50% 86 Beneish M-Score is -2.73 as of Jul. 06, 2026. GuruFocus rates FRA:MM3 with a GF Score™ of 86/100 and a GF Value™ of €83.98 (Modestly Undervalued). Among 764 Medical Devices & Instruments companies, Merit Medical Systems ranks better than 62.43% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.73 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Merit Medical Systems's Beneish M-Score or its related term are showing as below:

FRA:MM3' s Beneish M-Score Range Over the Past 10 Years
Min: -2.87   Med: -2.57   Max: -2.29
Current: -2.73

During the past 13 years, the highest Beneish M-Score of Merit Medical Systems was -2.29. The lowest was -2.87. And the median was -2.57.


Merit Medical Systems Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Merit Medical Systems's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Merit Medical Systems Beneish M-Score Chart

Merit Medical Systems Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.64 -2.50 -2.84 -2.44 -2.72

Merit Medical Systems Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.44 -2.41 -2.58 -2.72 -2.73

FRA:MM3 vs NVST, MMED, ICUI: Beneish M-Score Comparison

For the Medical Instruments & Supplies subindustry, Merit Medical Systems's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merit Medical Systems Beneish M-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Merit Medical Systems's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Merit Medical Systems's Beneish M-Score falls into.


FRA:MM3
86GF Score
Merit Medical Systems Inc FRA:MM3
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Merit Medical Systems Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Merit Medical Systems for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9516+0.528 * 0.9821+0.404 * 0.9656+0.892 * 1.0292+0.115 * 0.9792
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0155+4.679 * -0.061391-0.327 * 0.9276
=-2.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was €196 Mil.
Revenue was 330.324 + 336.421 + 327.302 + 331.595 = €1,326 Mil.
Gross Profit was 159.849 + 166.831 + 158.822 + 159.95 = €645 Mil.
Total Current Assets was €953 Mil.
Total Assets was €2,352 Mil.
Property, Plant and Equipment(Net PPE) was €450 Mil.
Depreciation, Depletion and Amortization(DDA) was €117 Mil.
Selling, General, & Admin. Expense(SGA) was €400 Mil.
Total Current Liabilities was €188 Mil.
Long-Term Debt & Capital Lease Obligation was €701 Mil.
Net Income was 35.461 + 32.457 + 23.647 + 28.248 = €120 Mil.
Non Operating Income was 10.548 + -0.394 + -0.822 + -0.546 = €9 Mil.
Cash Flow from Operations was 35.189 + 84.128 + 63.885 + 72.227 = €255 Mil.
Total Receivables was €200 Mil.
Revenue was 328.7 + 339.176 + 306.2 + 314.005 = €1,288 Mil.
Gross Profit was 159.118 + 165.199 + 141.939 + 149.662 = €616 Mil.
Total Current Assets was €887 Mil.
Total Assets was €2,283 Mil.
Property, Plant and Equipment(Net PPE) was €442 Mil.
Depreciation, Depletion and Amortization(DDA) was €112 Mil.
Selling, General, & Admin. Expense(SGA) was €383 Mil.
Total Current Liabilities was €182 Mil.
Long-Term Debt & Capital Lease Obligation was €748 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(196.356 / 1325.642) / (200.49 / 1288.081)
=0.148121 / 0.15565
=0.9516

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(615.918 / 1288.081) / (645.452 / 1325.642)
=0.478167 / 0.486898
=0.9821

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (953.035 + 450.088) / 2352.181) / (1 - (886.737 + 442.193) / 2282.875)
=0.40348 / 0.41787
=0.9656

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1325.642 / 1288.081
=1.0292

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(111.616 / (111.616 + 442.193)) / (116.645 / (116.645 + 450.088))
=0.201542 / 0.20582
=0.9792

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(400.442 / 1325.642) / (383.149 / 1288.081)
=0.302074 / 0.297457
=1.0155

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((700.94 + 187.596) / 2352.181) / ((747.605 + 182.061) / 2282.875)
=0.37775 / 0.407235
=0.9276

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(119.813 - 8.786 - 255.429) / 2352.181
=-0.061391

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Merit Medical Systems has a M-score of -2.79 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.73 mean?
Merit Medical Systems (FRA:MM3) has a Beneish M-Score of -2.73 as of Jul. 06, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Merit Medical Systems and its competitors. According to the industry distribution chart, Merit Medical Systems ranks #287 out of 764 companies in the Medical Devices & Instruments industry, placing it in the top 37.6%.
Is Merit Medical Systems' Beneish M-Score too high?
Merit Medical Systems' current Beneish M-Score is -2.73. Based on the distribution chart, Merit Medical Systems ranks #287 out of 764 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Merit Medical Systems has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Merit Medical Systems' Beneish M-Score compare to NVST and MMED?
According to the Medical Devices & Instruments industry distribution chart, Merit Medical Systems ranks #287 out of 764 companies for Beneish M-Score. This puts Merit Medical Systems in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Merit Medical Systems and its competitors. Merit Medical Systems's current Beneish M-Score is -2.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Merit Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Merit Medical Systems (FRA:MM3) is currently considered Modestly Undervalued. The stock's GF Value™ is €83.98, compared to a current price of €61.50 — trading 26.8% below its estimated fair value. The current Beneish M-Score is -2.73. Merit Medical Systems' overall GF Score™ is 86/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Merit Medical Systems (FRA:MM3), the current Beneish M-Score is -2.73 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Merit Medical Systems (FRA:MM3) Overvalued in 2026?

Based on GuruFocus' analysis, Merit Medical Systems stock appears to be undervalued. The current stock price of €61.50 is trading 26.8% below its estimated GF Value™ of €83.98. GuruFocus considers Merit Medical Systems to be Modestly Undervalued.

Key valuation signals for FRA:MM3:

  • Beneish M-Score: -2.73
  • GF Value™: €83.98 vs. price of €61.50 (26.8% below fair value)
  • GF Score™: 86/100

No single metric tells the full story. See the FRA:MM3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Merit Medical Systems Business Description

Other Exchanges MMSI:USA
Address 1600 West Merit Parkway, South Jordan, UT, USA, 84095
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
86GF Score

Get the complete analysis for FRA:MM3

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€61.50
Price
€83.98
GF Value